He says patented at the end but stop short of saying it does not belong to IVX.
The ownership and patent belongs to the Cho Group who is providing the funding.
Mate, just send an email to the company and it will be clear.
Ann: Complete Regression of TNBC Tumours and Protective Immunity, page-138
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.004(4.17%) |
Mkt cap ! $8.541M | |||
| Open | High | Low | Value | Volume |
| 9.7¢ | 10.0¢ | 9.6¢ | $6.613K | 66.75K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 75887 | 9.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 294638 | 3 |
View Market Depth
| Last trade - 15.14pm 30/07/2025 (20 minute delay) ? |
| IVX (ASX) Chart |